IRIS
RUGGERI, Rosaria Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.758
NA - Nord America 10.569
AS - Asia 6.672
SA - Sud America 2.355
AF - Africa 235
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 38.621
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.355
RU - Federazione Russa 7.139
IT - Italia 5.856
SG - Singapore 2.747
BR - Brasile 2.003
CN - Cina 1.865
IE - Irlanda 1.532
SE - Svezia 1.327
HK - Hong Kong 730
DE - Germania 611
FR - Francia 561
VN - Vietnam 425
NL - Olanda 347
UA - Ucraina 345
FI - Finlandia 334
GB - Regno Unito 289
IN - India 247
AR - Argentina 128
BD - Bangladesh 100
PL - Polonia 100
CA - Canada 99
TR - Turchia 78
ZA - Sudafrica 72
IQ - Iraq 71
MX - Messico 69
EC - Ecuador 56
CO - Colombia 52
AT - Austria 51
CZ - Repubblica Ceca 51
JP - Giappone 47
BE - Belgio 45
ID - Indonesia 43
MA - Marocco 43
PK - Pakistan 43
UZ - Uzbekistan 42
VE - Venezuela 33
ES - Italia 31
SA - Arabia Saudita 29
CH - Svizzera 27
CL - Cile 26
TN - Tunisia 26
CI - Costa d'Avorio 24
AE - Emirati Arabi Uniti 18
IR - Iran 18
PE - Perù 18
KE - Kenya 17
LT - Lituania 17
AZ - Azerbaigian 16
DZ - Algeria 16
EG - Egitto 15
PY - Paraguay 15
KZ - Kazakistan 14
MY - Malesia 14
PH - Filippine 14
DO - Repubblica Dominicana 13
AL - Albania 12
AU - Australia 12
IL - Israele 12
JO - Giordania 12
UY - Uruguay 11
RS - Serbia 10
BG - Bulgaria 9
BO - Bolivia 9
PS - Palestinian Territory 9
DK - Danimarca 8
EU - Europa 8
LB - Libano 8
NP - Nepal 8
PT - Portogallo 8
RO - Romania 8
KG - Kirghizistan 7
BY - Bielorussia 6
CR - Costa Rica 6
GE - Georgia 6
GR - Grecia 6
HU - Ungheria 6
JM - Giamaica 6
LV - Lettonia 6
OM - Oman 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
PA - Panama 5
SY - Repubblica araba siriana 5
KR - Corea 4
LK - Sri Lanka 4
NG - Nigeria 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
KW - Kuwait 3
MM - Myanmar 3
SR - Suriname 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
CY - Cipro 2
Totale 38.581
Salva come PNG Salva come JPEG
Città #
Moscow 1.951
Ashburn 1.600
Dublin 1.526
Singapore 1.507
Dallas 1.235
Chandler 1.209
Hong Kong 727
Nyköping 700
Jacksonville 690
Beijing 683
Milan 523
Rome 451
San Jose 421
Messina 361
The Dalles 355
Princeton 262
Los Angeles 257
Lauterbourg 247
Dearborn 244
Medford 227
New York 217
Cambridge 204
Naples 191
Munich 187
Des Moines 185
Ann Arbor 162
São Paulo 148
Ho Chi Minh City 130
Buffalo 116
Turin 112
Boardman 107
Bologna 97
Bremen 93
Catania 89
Bari 86
Palermo 84
Jinan 78
Hanoi 77
Tianjin 77
Redondo Beach 76
Warsaw 76
Turku 75
Wilmington 72
Florence 71
Guangzhou 71
Lancaster 65
Council Bluffs 64
Pune 61
Helsinki 60
Genoa 59
Dong Ket 58
Hyderabad 58
Nanjing 57
San Mateo 57
Frankfurt am Main 56
Woodbridge 54
Rio de Janeiro 51
Orem 50
Shenyang 50
Brasília 45
Belo Horizonte 43
Brussels 43
Santa Clara 43
Johannesburg 42
Tokyo 42
Houston 40
Brooklyn 39
Denver 39
Seattle 38
Vienna 36
Zhengzhou 36
Tashkent 35
London 34
Montreal 34
Brescia 33
Porto Alegre 33
Chennai 31
Shenzhen 31
San Francisco 30
Cagliari 29
Hebei 29
Modena 28
Ningbo 28
Haikou 27
Nuremberg 27
Parma 27
Shanghai 27
Trieste 27
Verona 27
Brno 26
Abidjan 24
Baghdad 24
Hangzhou 24
Pisa 24
Salvador 24
Stockholm 24
Taizhou 24
Chicago 23
Curitiba 23
Monza 23
Totale 20.143
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.565
I LIVELLI SIERICI DI INTERLEUCHINA 23 (IL-23) SONO AUMENTATI NEI PAZIENTI CON TIROIDITE DI HASHIMOTO (TH) DI NUOVA DIAGNOSI RISPETTO AI CONTROLLI SANI 704
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 323
IL GRADO DI COINVOLGIMENTO CUTANEO, VALUTATO COME SKIN SCORE SECONDO RODNAN, NEI PAZIENTI CON SCLEROSI SISTEMICA (SS) CORRELA CON I LIVELLI SIERICI DI TSH 321
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 269
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 254
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 244
I livelli sierici di interleuchina 22 (IL-22) sono aumentati nella tiroidite di Hashimoto rispetto alle tireopatie non autoimmuni ed ai controlli sani. 204
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 203
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 202
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 196
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 196
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 190
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 190
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 189
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 188
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 187
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 187
Association of parathyroid carcinoma and thyroid disorders: A clinical review 185
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 183
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 183
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 181
Hyaluronan oligosaccharides induce inflammatory response in human thyrocytes cultures by affecting Toll-like receptors 180
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 180
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 179
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 178
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 178
AUMENTATO STRESS OSSIDATIVO NELLA TIROIDITE DI HASHIMOTO (TH) CON EUTIROIDISMO 178
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 177
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 176
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 176
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 176
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 176
Un caso di orticaria cronica idiopatica (OCI) associata a morbo di Basedow (MB): tipizzazione HLA. 174
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 174
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 171
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 170
I livelli sierici di Interleuchina 37 (IL-37) sono aumentati nella Tiroidite di Hashimoto (TH) e correlano con i marcatori di stress ossidativo 170
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 170
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 170
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 169
HER2 analysis in sporadic thyroid cancer of follicular cell origin 169
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 169
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 167
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 167
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 167
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 166
Oxidative stress as a key feature of autoimmune thyroiditis: an update 165
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 164
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 164
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 164
Adverse childhood experiences and negative emotional responses : risk factors for thyroid autoimmune diseases? 164
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 163
Malattie della Tiroide-Note di anatomia e fisiologia 162
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 162
Hyaluronan oligosaccharides modulate inflammatory response, NIS and thyreoglobulin expression in human thyrocytes 161
Could AGE/RAGE-related oxidative homeostasis dysregulation enhance susceptibility to pathogenesis of cardio-metabolic complications in childhood obesity? 160
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 160
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 159
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 159
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 158
Predictive markers of recurrence in radically resected pituitary macroadenomas 157
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 157
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 157
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 156
Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women 156
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 155
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 155
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Hyperthyroidism treatment with calculated activity of 131–radioiodine 154
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 153
An uncommon case of Marine-Lenhart syndrome 153
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 152
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 152
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 152
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 151
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 150
Iodine-131 treatment of hyperthyroidism: our experience 150
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 150
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 149
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 148
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 148
IODINE-131 TREATMENT OF HYPERTHYROIDISM:OUR EXPERIENCE. 147
La paratiroidectomia radioguidata 147
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 147
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 147
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 146
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 146
Hyaluronan oligosaccharides down-regulate NIS and thyroglobulin expression in human thyrocytes 145
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 144
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 144
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 142
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 142
Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine 141
Comment on “Prevalence of undifferentiated inflammatory arthropathy in patients with Hashimoto's thyroiditis in an endocrinology clinic” by Luis M. Valderrama-Hinds and co-workers. Int J Rheum Dis 2019; 22: 1985-1989 141
Importanza del campionamento precoce del TSH, basale e stimolato dal TRH, nell'ipotiroidismo subclinico 140
un caso di carcinoma delle paratiroidi associato ad adenoma autonomo omolaterale della tiroide 140
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 140
Non-specific rheumatic manifestations in patients with Hashimoto's thyroiditis: a pilot cross-sectional study 140
Totale 21.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.972
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 0 0 0 0 137 139 120
2021/20221.864 25 215 43 105 77 29 101 95 38 299 248 589
2022/20234.814 363 431 232 340 385 536 78 273 1.867 45 180 84
2023/20242.551 111 191 169 216 179 425 121 183 102 271 199 384
2024/20258.372 298 243 373 620 587 405 381 1.528 1.574 588 685 1.090
2025/202617.104 999 1.266 1.275 1.105 1.483 3.594 2.115 2.164 2.357 746 0 0
Totale 39.169